A 45-year-old patient presented with progressive muscle weakness with onset in the legs, followed later by loss of muscle force in the arms and dysarthria. On clinical examination, the patient had signs upper motor neuron dysfunction with hyperreflexia in the four limbs, bilateral extensor plantar responses, an exaggerated masseter reflex, and an increased muscle tone in the lower limbs. Muscle weakness was noted in the neck flexors, in the distal upper limb muscles and more widespread in the lower limbs. The intrinsic hand muscles were most atrophied, but milder loss of muscle bulk was noted in the limbs and tongue. Ancillary tests did not reveal alternative explanations. The FTD-PET scan of the brain is shown in the figure (the stereotactic surface projections of brain FDG-PET are shown in the upper row, the corresponding Z-score images in the lower row). fx1
limb muscles and more widespread in the lower limbs. The intrinsic hand muscles were most atrophied, but milder loss of muscle bulk was noted in the limbs and tongue. Ancillary tests did not reveal alternative explanations. The FTD-PET scan of the brain is shown in the figure (the stereotactic surface projections of brain FDG-PET are shown in the upper row, the corresponding Z-score images in the lower row). In this patient, the clinical presentation is compatible with classical ALS, as a combination of signs of upper and lower motor neuron degeneration are present in several body regions. FDG-PET can help to detect motor and extramotor involvement in patients with motor neuron disorders. Here, marked hypometabolism is present in the motor cortex bilaterally.
